Structure

Physi-Chem Properties

Molecular Weight:  606.34
Volume:  613.898
LogP:  3.11
LogD:  2.57
LogS:  -4.361
# Rotatable Bonds:  8
TPSA:  167.66
# H-Bond Aceptor:  10
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.238
Synthetic Accessibility Score:  5.328
Fsp3:  0.879
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.33
MDCK Permeability:  5.400877489591949e-05
Pgp-inhibitor:  0.979
Pgp-substrate:  0.885
Human Intestinal Absorption (HIA):  0.462
20% Bioavailability (F20%):  0.014
30% Bioavailability (F30%):  0.523

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.098
Plasma Protein Binding (PPB):  89.83695983886719%
Volume Distribution (VD):  0.397
Pgp-substrate:  4.428019046783447%

ADMET: Metabolism

CYP1A2-inhibitor:  0.005
CYP1A2-substrate:  0.197
CYP2C19-inhibitor:  0.008
CYP2C19-substrate:  0.393
CYP2C9-inhibitor:  0.036
CYP2C9-substrate:  0.117
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.11
CYP3A4-inhibitor:  0.022
CYP3A4-substrate:  0.057

ADMET: Excretion

Clearance (CL):  3.74
Half-life (T1/2):  0.649

ADMET: Toxicity

hERG Blockers:  0.054
Human Hepatotoxicity (H-HT):  0.268
Drug-inuced Liver Injury (DILI):  0.456
AMES Toxicity:  0.035
Rat Oral Acute Toxicity:  0.714
Maximum Recommended Daily Dose:  0.889
Skin Sensitization:  0.244
Carcinogencity:  0.411
Eye Corrosion:  0.003
Eye Irritation:  0.009
Respiratory Toxicity:  0.716

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC178548

Natural Product ID:  NPC178548
Common Name*:   Pandaroside D
IUPAC Name:   (2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[[(3S,5S,8R,9S,10S,13S,14R)-16-hydroxy-10,13-dimethyl-17-[(2R)-6-methyl-4-oxoheptan-2-yl]-15-oxo-1,2,3,4,5,6,7,8,9,11,12,14-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]oxane-2-carboxylic acid
Synonyms:   Pandaroside D
Standard InCHIKey:  CFFDFUDCYHFINU-HSSSCCAZSA-N
Standard InCHI:  InChI=1S/C33H50O10/c1-15(2)12-18(34)13-16(3)22-24(35)25(36)23-20-7-6-17-14-19(8-10-32(17,4)21(20)9-11-33(22,23)5)42-31-28(39)26(37)27(38)29(43-31)30(40)41/h15-17,19-21,23,26-29,31,35,37-39H,6-14H2,1-5H3,(H,40,41)/t16-,17+,19+,20-,21+,23+,26+,27+,28-,29+,31-,32+,33-/m1/s1
SMILES:  CC(C)CC(=O)C[C@@H](C)C1=C(C(=O)[C@@H]2[C@@H]3CC[C@H]4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](C(=O)O)O1)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1214515
PubChem CID:   44191620
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001013] Steroidal glycosides
          • [CHEMONTID:0001447] Steroid glucuronide conjugates

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20847 Pandaros acanthifolium Species Clathriidae Eukaryota n.a. n.a. n.a. PMID[20614907]
NPO20847 Pandaros acanthifolium Species Clathriidae Eukaryota n.a. Caribbean n.a. PMID[23245401]
NPO20847 Pandaros acanthifolium Species Clathriidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT839 Cell Line L6 Rattus norvegicus Activity = 96.6 uM PMID[531417]
NPT844 Organism Trypanosoma brucei rhodesiense Trypanosoma brucei rhodesiense IC50 = 15300.0 nM PMID[531417]
NPT580 Organism Trypanosoma cruzi Trypanosoma cruzi IC50 = 80800.0 nM PMID[531417]
NPT633 Organism Leishmania donovani Leishmania donovani IC50 = 31000.0 nM PMID[531417]
NPT485 Organism Plasmodium falciparum (isolate K1 / Thailand) Plasmodium falciparum K1 IC50 = 13500.0 nM PMID[531417]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC178548 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC258592
0.982 High Similarity NPC258815
0.982 High Similarity NPC194310
0.982 High Similarity NPC169727
0.982 High Similarity NPC258789
0.982 High Similarity NPC47567
0.982 High Similarity NPC241310
0.982 High Similarity NPC131841
0.982 High Similarity NPC412
0.9561 High Similarity NPC469842
0.9561 High Similarity NPC469841
0.9469 High Similarity NPC187950
0.9469 High Similarity NPC278163
0.9391 High Similarity NPC177820
0.9391 High Similarity NPC30188
0.9224 High Similarity NPC7850
0.9224 High Similarity NPC6615
0.8889 High Similarity NPC471965
0.8824 High Similarity NPC285091
0.8814 High Similarity NPC14617
0.8814 High Similarity NPC471964
0.8814 High Similarity NPC202666
0.8814 High Similarity NPC262199
0.8814 High Similarity NPC471961
0.8793 High Similarity NPC319570
0.8739 High Similarity NPC247315
0.8739 High Similarity NPC471962
0.8739 High Similarity NPC471963
0.8718 High Similarity NPC476849
0.8707 High Similarity NPC286347
0.8707 High Similarity NPC239293
0.8667 High Similarity NPC87662
0.8632 High Similarity NPC473884
0.8632 High Similarity NPC35405
0.8632 High Similarity NPC469945
0.8632 High Similarity NPC11551
0.8632 High Similarity NPC475171
0.8632 High Similarity NPC157868
0.8632 High Similarity NPC214484
0.8632 High Similarity NPC472949
0.8632 High Similarity NPC309780
0.8632 High Similarity NPC6377
0.8632 High Similarity NPC180550
0.8632 High Similarity NPC208381
0.8632 High Similarity NPC114441
0.8632 High Similarity NPC39211
0.8621 High Similarity NPC224121
0.8621 High Similarity NPC477252
0.8596 High Similarity NPC477253
0.8571 High Similarity NPC107966
0.8571 High Similarity NPC249848
0.8571 High Similarity NPC40775
0.8571 High Similarity NPC235438
0.8571 High Similarity NPC162574
0.8559 High Similarity NPC294112
0.8534 High Similarity NPC173686
0.8534 High Similarity NPC16081
0.8512 High Similarity NPC47113
0.8512 High Similarity NPC174367
0.85 High Similarity NPC281148
0.85 High Similarity NPC1980
0.85 High Similarity NPC30735
0.85 High Similarity NPC235405
0.85 High Similarity NPC238005
0.85 High Similarity NPC141196
0.8487 Intermediate Similarity NPC470478
0.8487 Intermediate Similarity NPC62725
0.8487 Intermediate Similarity NPC223301
0.8487 Intermediate Similarity NPC86222
0.8487 Intermediate Similarity NPC301449
0.8487 Intermediate Similarity NPC104372
0.8487 Intermediate Similarity NPC75417
0.8487 Intermediate Similarity NPC297263
0.8487 Intermediate Similarity NPC171544
0.8487 Intermediate Similarity NPC242840
0.8487 Intermediate Similarity NPC31838
0.8487 Intermediate Similarity NPC64715
0.8487 Intermediate Similarity NPC22956
0.8487 Intermediate Similarity NPC222580
0.8487 Intermediate Similarity NPC159309
0.8487 Intermediate Similarity NPC31193
0.8487 Intermediate Similarity NPC114484
0.8487 Intermediate Similarity NPC11242
0.8475 Intermediate Similarity NPC127530
0.8455 Intermediate Similarity NPC54614
0.8455 Intermediate Similarity NPC309096
0.8448 Intermediate Similarity NPC45218
0.8448 Intermediate Similarity NPC268238
0.8448 Intermediate Similarity NPC323821
0.8448 Intermediate Similarity NPC143268
0.843 Intermediate Similarity NPC130229
0.843 Intermediate Similarity NPC470477
0.8417 Intermediate Similarity NPC4749
0.8417 Intermediate Similarity NPC236870
0.8417 Intermediate Similarity NPC80986
0.8417 Intermediate Similarity NPC21691
0.8417 Intermediate Similarity NPC10607
0.8417 Intermediate Similarity NPC187290
0.8417 Intermediate Similarity NPC475591
0.8417 Intermediate Similarity NPC275343
0.8417 Intermediate Similarity NPC213952
0.8403 Intermediate Similarity NPC236657
0.8403 Intermediate Similarity NPC118440
0.839 Intermediate Similarity NPC297179
0.8374 Intermediate Similarity NPC295220
0.8374 Intermediate Similarity NPC475636
0.8362 Intermediate Similarity NPC73986
0.8361 Intermediate Similarity NPC181066
0.8361 Intermediate Similarity NPC469947
0.8361 Intermediate Similarity NPC470218
0.8361 Intermediate Similarity NPC198714
0.8347 Intermediate Similarity NPC258617
0.8347 Intermediate Similarity NPC227397
0.8347 Intermediate Similarity NPC200049
0.8347 Intermediate Similarity NPC478066
0.8347 Intermediate Similarity NPC44716
0.8347 Intermediate Similarity NPC2370
0.8347 Intermediate Similarity NPC283417
0.8347 Intermediate Similarity NPC302543
0.8347 Intermediate Similarity NPC257211
0.8333 Intermediate Similarity NPC302887
0.8333 Intermediate Similarity NPC275675
0.8333 Intermediate Similarity NPC187618
0.8333 Intermediate Similarity NPC42675
0.8319 Intermediate Similarity NPC473920
0.8319 Intermediate Similarity NPC192791
0.8319 Intermediate Similarity NPC232258
0.8306 Intermediate Similarity NPC477196
0.8305 Intermediate Similarity NPC309433
0.8305 Intermediate Similarity NPC473304
0.8291 Intermediate Similarity NPC472274
0.8291 Intermediate Similarity NPC18547
0.8291 Intermediate Similarity NPC474906
0.8279 Intermediate Similarity NPC475194
0.8279 Intermediate Similarity NPC33068
0.8279 Intermediate Similarity NPC160452
0.8279 Intermediate Similarity NPC318135
0.8276 Intermediate Similarity NPC471967
0.8268 Intermediate Similarity NPC262813
0.8264 Intermediate Similarity NPC313110
0.8264 Intermediate Similarity NPC131469
0.8264 Intermediate Similarity NPC216866
0.825 Intermediate Similarity NPC471406
0.824 Intermediate Similarity NPC134914
0.824 Intermediate Similarity NPC262796
0.824 Intermediate Similarity NPC329993
0.824 Intermediate Similarity NPC173435
0.824 Intermediate Similarity NPC264566
0.824 Intermediate Similarity NPC477197
0.824 Intermediate Similarity NPC476074
0.824 Intermediate Similarity NPC478155
0.824 Intermediate Similarity NPC301639
0.824 Intermediate Similarity NPC475377
0.824 Intermediate Similarity NPC478065
0.824 Intermediate Similarity NPC45346
0.824 Intermediate Similarity NPC172374
0.824 Intermediate Similarity NPC25998
0.824 Intermediate Similarity NPC475167
0.824 Intermediate Similarity NPC478064
0.8235 Intermediate Similarity NPC176005
0.8235 Intermediate Similarity NPC291564
0.8235 Intermediate Similarity NPC109588
0.8226 Intermediate Similarity NPC477193
0.8226 Intermediate Similarity NPC477194
0.8226 Intermediate Similarity NPC477191
0.8226 Intermediate Similarity NPC477192
0.8226 Intermediate Similarity NPC475281
0.8226 Intermediate Similarity NPC329923
0.8226 Intermediate Similarity NPC293623
0.8226 Intermediate Similarity NPC477078
0.8226 Intermediate Similarity NPC477075
0.8226 Intermediate Similarity NPC168899
0.8226 Intermediate Similarity NPC69273
0.822 Intermediate Similarity NPC31797
0.822 Intermediate Similarity NPC235539
0.822 Intermediate Similarity NPC88945
0.822 Intermediate Similarity NPC134869
0.822 Intermediate Similarity NPC152199
0.8211 Intermediate Similarity NPC475368
0.8211 Intermediate Similarity NPC284449
0.8211 Intermediate Similarity NPC104427
0.8211 Intermediate Similarity NPC273962
0.8205 Intermediate Similarity NPC255017
0.8205 Intermediate Similarity NPC260665
0.8205 Intermediate Similarity NPC62696
0.8205 Intermediate Similarity NPC293038
0.8203 Intermediate Similarity NPC251998
0.8203 Intermediate Similarity NPC141215
0.8203 Intermediate Similarity NPC471089
0.8203 Intermediate Similarity NPC190065
0.819 Intermediate Similarity NPC285410
0.819 Intermediate Similarity NPC263827
0.819 Intermediate Similarity NPC250481
0.819 Intermediate Similarity NPC31839
0.819 Intermediate Similarity NPC11035
0.819 Intermediate Similarity NPC272242
0.8189 Intermediate Similarity NPC478069
0.8182 Intermediate Similarity NPC129434
0.8182 Intermediate Similarity NPC202051
0.8175 Intermediate Similarity NPC478152

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC178548 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8814 High Similarity NPD8328 Phase 3
0.8783 High Similarity NPD8295 Clinical (unspecified phase)
0.8374 Intermediate Similarity NPD7736 Approved
0.8174 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.8145 Intermediate Similarity NPD8293 Discontinued
0.8016 Intermediate Similarity NPD7319 Approved
0.7967 Intermediate Similarity NPD6370 Approved
0.792 Intermediate Similarity NPD7507 Approved
0.7845 Intermediate Similarity NPD6412 Phase 2
0.784 Intermediate Similarity NPD7492 Approved
0.7805 Intermediate Similarity NPD6059 Approved
0.7805 Intermediate Similarity NPD6319 Approved
0.7805 Intermediate Similarity NPD6054 Approved
0.7778 Intermediate Similarity NPD6616 Approved
0.7717 Intermediate Similarity NPD7078 Approved
0.7667 Intermediate Similarity NPD6882 Approved
0.7667 Intermediate Similarity NPD8297 Approved
0.7627 Intermediate Similarity NPD6686 Approved
0.7603 Intermediate Similarity NPD8133 Approved
0.76 Intermediate Similarity NPD6016 Approved
0.76 Intermediate Similarity NPD6015 Approved
0.7563 Intermediate Similarity NPD6373 Approved
0.7563 Intermediate Similarity NPD6372 Approved
0.7561 Intermediate Similarity NPD6009 Approved
0.754 Intermediate Similarity NPD5988 Approved
0.7521 Intermediate Similarity NPD8170 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD6675 Approved
0.7458 Intermediate Similarity NPD6402 Approved
0.7458 Intermediate Similarity NPD7128 Approved
0.7458 Intermediate Similarity NPD5739 Approved
0.7438 Intermediate Similarity NPD6650 Approved
0.7438 Intermediate Similarity NPD6649 Approved
0.7381 Intermediate Similarity NPD8294 Approved
0.7381 Intermediate Similarity NPD8377 Approved
0.736 Intermediate Similarity NPD7328 Approved
0.736 Intermediate Similarity NPD7327 Approved
0.7333 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD6899 Approved
0.7333 Intermediate Similarity NPD7320 Approved
0.7333 Intermediate Similarity NPD6881 Approved
0.7323 Intermediate Similarity NPD8033 Approved
0.7323 Intermediate Similarity NPD8378 Approved
0.7323 Intermediate Similarity NPD8380 Approved
0.7323 Intermediate Similarity NPD8335 Approved
0.7323 Intermediate Similarity NPD8296 Approved
0.7323 Intermediate Similarity NPD8379 Approved
0.7317 Intermediate Similarity NPD4632 Approved
0.7302 Intermediate Similarity NPD7516 Approved
0.7295 Intermediate Similarity NPD8130 Phase 1
0.7252 Intermediate Similarity NPD6033 Approved
0.725 Intermediate Similarity NPD5697 Approved
0.725 Intermediate Similarity NPD5701 Approved
0.7213 Intermediate Similarity NPD7290 Approved
0.7213 Intermediate Similarity NPD6883 Approved
0.7213 Intermediate Similarity NPD7102 Approved
0.7154 Intermediate Similarity NPD6617 Approved
0.7154 Intermediate Similarity NPD6869 Approved
0.7154 Intermediate Similarity NPD6847 Approved
0.7132 Intermediate Similarity NPD8080 Discontinued
0.7131 Intermediate Similarity NPD6014 Approved
0.7131 Intermediate Similarity NPD6013 Approved
0.7131 Intermediate Similarity NPD6012 Approved
0.7077 Intermediate Similarity NPD7604 Phase 2
0.7073 Intermediate Similarity NPD4634 Approved
0.7054 Intermediate Similarity NPD8513 Phase 3
0.7054 Intermediate Similarity NPD8516 Approved
0.7054 Intermediate Similarity NPD5983 Phase 2
0.7054 Intermediate Similarity NPD8517 Approved
0.7054 Intermediate Similarity NPD7503 Approved
0.7054 Intermediate Similarity NPD8515 Approved
0.7049 Intermediate Similarity NPD6011 Approved
0.7016 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7009 Intermediate Similarity NPD7902 Approved
0.7009 Intermediate Similarity NPD6083 Phase 2
0.7009 Intermediate Similarity NPD6084 Phase 2
0.7008 Intermediate Similarity NPD7115 Discovery
0.697 Remote Similarity NPD6336 Discontinued
0.6923 Remote Similarity NPD8274 Clinical (unspecified phase)
0.6897 Remote Similarity NPD7748 Approved
0.687 Remote Similarity NPD8034 Phase 2
0.687 Remote Similarity NPD8035 Phase 2
0.6864 Remote Similarity NPD4755 Approved
0.6855 Remote Similarity NPD4061 Clinical (unspecified phase)
0.681 Remote Similarity NPD6399 Phase 3
0.6807 Remote Similarity NPD5696 Approved
0.6807 Remote Similarity NPD7638 Approved
0.68 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6797 Remote Similarity NPD6274 Approved
0.6794 Remote Similarity NPD6921 Approved
0.678 Remote Similarity NPD4697 Phase 3
0.6769 Remote Similarity NPD7101 Approved
0.6769 Remote Similarity NPD7100 Approved
0.6754 Remote Similarity NPD5737 Approved
0.6754 Remote Similarity NPD6672 Approved
0.6752 Remote Similarity NPD7900 Approved
0.6752 Remote Similarity NPD7901 Clinical (unspecified phase)
0.675 Remote Similarity NPD4696 Approved
0.675 Remote Similarity NPD4700 Approved
0.675 Remote Similarity NPD5285 Approved
0.675 Remote Similarity NPD7639 Approved
0.675 Remote Similarity NPD5286 Approved
0.675 Remote Similarity NPD7640 Approved
0.6748 Remote Similarity NPD6008 Approved
0.6724 Remote Similarity NPD7515 Phase 2
0.6696 Remote Similarity NPD5328 Approved
0.6695 Remote Similarity NPD5695 Phase 3
0.6692 Remote Similarity NPD6067 Discontinued
0.6692 Remote Similarity NPD6335 Approved
0.6667 Remote Similarity NPD8171 Discontinued
0.6667 Remote Similarity NPD6868 Approved
0.6667 Remote Similarity NPD6908 Approved
0.6667 Remote Similarity NPD6909 Approved
0.6642 Remote Similarity NPD5956 Approved
0.6639 Remote Similarity NPD5211 Phase 2
0.6639 Remote Similarity NPD5221 Approved
0.6639 Remote Similarity NPD5224 Approved
0.6639 Remote Similarity NPD5222 Approved
0.6639 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6639 Remote Similarity NPD7632 Discontinued
0.6639 Remote Similarity NPD5225 Approved
0.6639 Remote Similarity NPD4633 Approved
0.6639 Remote Similarity NPD5226 Approved
0.6618 Remote Similarity NPD8336 Approved
0.6618 Remote Similarity NPD8337 Approved
0.6615 Remote Similarity NPD6317 Approved
0.6615 Remote Similarity NPD8137 Clinical (unspecified phase)
0.6614 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6613 Remote Similarity NPD4767 Approved
0.6613 Remote Similarity NPD4768 Approved
0.661 Remote Similarity NPD5282 Discontinued
0.6585 Remote Similarity NPD5175 Approved
0.6585 Remote Similarity NPD5174 Approved
0.6583 Remote Similarity NPD5173 Approved
0.6581 Remote Similarity NPD6079 Approved
0.6565 Remote Similarity NPD6313 Approved
0.6565 Remote Similarity NPD6314 Approved
0.656 Remote Similarity NPD5954 Clinical (unspecified phase)
0.656 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6557 Remote Similarity NPD5223 Approved
0.6538 Remote Similarity NPD6940 Discontinued
0.6532 Remote Similarity NPD5141 Approved
0.6529 Remote Similarity NPD4225 Approved
0.6508 Remote Similarity NPD4730 Approved
0.6508 Remote Similarity NPD4729 Approved
0.6491 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6466 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6452 Remote Similarity NPD4754 Approved
0.6441 Remote Similarity NPD6411 Approved
0.6435 Remote Similarity NPD3618 Phase 1
0.6429 Remote Similarity NPD8338 Approved
0.6423 Remote Similarity NPD8074 Phase 3
0.642 Remote Similarity NPD7799 Discontinued
0.6418 Remote Similarity NPD6291 Clinical (unspecified phase)
0.641 Remote Similarity NPD6080 Approved
0.641 Remote Similarity NPD6673 Approved
0.641 Remote Similarity NPD6904 Approved
0.641 Remote Similarity NPD4753 Phase 2
0.641 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6406 Remote Similarity NPD6371 Approved
0.6406 Remote Similarity NPD5250 Approved
0.6406 Remote Similarity NPD5248 Approved
0.6406 Remote Similarity NPD5247 Approved
0.6406 Remote Similarity NPD5249 Phase 3
0.6406 Remote Similarity NPD5251 Approved
0.64 Remote Similarity NPD4057 Clinical (unspecified phase)
0.64 Remote Similarity NPD4056 Clinical (unspecified phase)
0.6378 Remote Similarity NPD5128 Approved
0.6364 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6357 Remote Similarity NPD7260 Phase 2
0.6319 Remote Similarity NPD6333 Approved
0.6319 Remote Similarity NPD6334 Approved
0.6312 Remote Similarity NPD6845 Suspended
0.6308 Remote Similarity NPD6053 Discontinued
0.6306 Remote Similarity NPD6115 Approved
0.6306 Remote Similarity NPD6114 Approved
0.6306 Remote Similarity NPD3617 Approved
0.6306 Remote Similarity NPD6697 Approved
0.6306 Remote Similarity NPD6118 Approved
0.6303 Remote Similarity NPD7983 Approved
0.6293 Remote Similarity NPD6409 Approved
0.6293 Remote Similarity NPD7334 Approved
0.6293 Remote Similarity NPD5330 Approved
0.6293 Remote Similarity NPD6684 Approved
0.6293 Remote Similarity NPD7146 Approved
0.6293 Remote Similarity NPD7521 Approved
0.629 Remote Similarity NPD1700 Approved
0.6281 Remote Similarity NPD5210 Approved
0.6281 Remote Similarity NPD4629 Approved
0.6271 Remote Similarity NPD6101 Approved
0.6271 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6261 Remote Similarity NPD4786 Approved
0.625 Remote Similarity NPD4202 Approved
0.6239 Remote Similarity NPD3573 Approved
0.6231 Remote Similarity NPD5215 Approved
0.6231 Remote Similarity NPD5216 Approved
0.6231 Remote Similarity NPD5217 Approved
0.6218 Remote Similarity NPD6698 Approved
0.6218 Remote Similarity NPD46 Approved
0.6216 Remote Similarity NPD6116 Phase 1
0.6194 Remote Similarity NPD7641 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data